L3VLUP
ProSign in

MSA · VRTX in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

MSAVRTX
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • MSA
  • VRTX
010203040202120222023202420252026
Holders and value by quarter
QuarterMSAVRTX
Q3 20204 holders, $493m31 holders, $21.9bn
Q4 20203 holders, $481m30 holders, $18.4bn
Q1 20213 holders, $246m31 holders, $15.4bn
Q2 20213 holders, $265m30 holders, $12.7bn
Q3 20213 holders, $229m35 holders, $10.1bn
Q4 20211 holders, $228m28 holders, $12.4bn
Q1 20221 holders, $197m23 holders, $16.1bn
Q2 20221 holders, $2.8m25 holders, $18.1bn
Q3 20221 holders, $1.3m22 holders, $18.4bn
Q4 20222 holders, $16m28 holders, $18.4bn
Q1 20232 holders, $30m26 holders, $21.4bn
Q2 20232 holders, $46m27 holders, $24.7bn
Q3 20231 holders, $35m33 holders, $24.3bn
Q4 20234 holders, $49m32 holders, $28.6bn
Q1 20247 holders, $294m31 holders, $29.8bn
Q2 20244 holders, $274m29 holders, $33.4bn
Q3 20244 holders, $248m27 holders, $33.5bn
Q4 20245 holders, $277m26 holders, $28.5bn
Q1 20256 holders, $247m21 holders, $35.4bn
Q2 20256 holders, $444m21 holders, $32.3bn
Q3 20255 holders, $385m22 holders, $25.9bn
Q4 20256 holders, $324m26 holders, $31.8bn
Q1 20267 holders, $354m25 holders, $31.8bn
Q2 20264 holders, $367m26 holders, $34.6bn
MSA

Msa Safety Inc

Holders
5
Reported value
$277m
Buyers
3
Sellers
1

Breadth +2 among 94 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
VRTX

Vertex Pharmaceuticals Inc

Holders
26
Reported value
$28.5bn
Buyers
14
Sellers
13

Breadth +1 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q4 2024

Among the 27 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only MSA (1)

Freestone Grove Partners LP

Only VRTX (22)

AllianceBernstein LP, AQR Capital Management LLC, ARK Investment Management LLC, Artisan Partners LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Capital Research Global Investors, Capital World Investors, D. E. Shaw & Co., ExodusPoint Capital Management LP, Fidelity (FMR LLC), Invesco Ltd, Man Group PLC, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, PDT Partners LLC, Renaissance Technologies LLC, Wellington Management Group LLP, Winton Group Ltd, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →